GeekWire April 2, 2024
Charlotte Schubert

Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington.

The hub combines “academic creativity with startup-style industrial execution,” said Jesse Gray, senior director of scientific operations and strategy, who was previously head of discovery at gene editing startup Ascidian Therapeutics.

The hub’s first main goal is to build a “biological recorder mouse,” enabling researchers to track biological actions such as cell divisions and molecular signaling in a live mouse across time.

Monday’s tour took place at the hub’s labs at Dexter Yard, a life sciences development in the South Lake Union neighborhood across from the Allen Institute, which is contributing $35...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article